ResearcherRussian Academy of SciencesActive in the last 2 years
Трачук Кирилл Николаевич
Matched on ORCID iD 0000-0002-2061-0274; OpenAlex author ID A5063800917. Sources: OpenAlex.
Their work
- Papers
- 3
- Trials
- 0
- Grants
- 0
- Labs led
- 0
- Collaborators
- 2
2025: 1 paper · 2026: 2 papers
Papers 3
- From Oncolysis to Adaptive Immunity: Yellow Fever Virus 17D and Ruxolitinib Activate Antitumor Immune Responses in Pancreatic Cancer Models. Co-author DOI 10.3390/biomedicines14081763↗
- Enhancement of oncolytic flavi- and alphavirus replication in resistant human pancreatic adenocarcinoma cell lines using ruxolitinib. Co-author DOI 10.36233/0507-4088-409↗
- Immunotherapeutic Potential of the Yellow Fever Virus Vaccine Strain 17D for Intratumoral Therapy in a Murine Model of Pancreatic Cancer. Co-author DOI 10.3390/vaccines13010040↗
Closest collaborators
The 2 strongest of 2 by collab_strength@1: shared papers, trials and grants, recent and small-team work weighing most.
- Назаренко Алина Сергеевна · 3 shared papers, 2025–2026 · strength 0.86
- Paper Enhancement of oncolytic flavi- and alphavirus replication in resistant human pancreatic adenocarcinoma cell lines usin… DOI 10.36233/0507-4088-409↗
- Paper From Oncolysis to Adaptive Immunity: Yellow Fever Virus 17D and Ruxolitinib Activate Antitumor Immune Responses in Panc… DOI 10.3390/biomedicines14081763↗
- Paper Immunotherapeutic Potential of the Yellow Fever Virus Vaccine Strain 17D for Intratumoral Therapy in a Murine Model of … DOI 10.3390/vaccines13010040↗
- Nadezhda M. Kolyasnikova · 3 shared papers, 2025–2026 · strength 0.86
- Paper Enhancement of oncolytic flavi- and alphavirus replication in resistant human pancreatic adenocarcinoma cell lines usin… DOI 10.36233/0507-4088-409↗
- Paper From Oncolysis to Adaptive Immunity: Yellow Fever Virus 17D and Ruxolitinib Activate Antitumor Immune Responses in Panc… DOI 10.3390/biomedicines14081763↗
- Paper Immunotherapeutic Potential of the Yellow Fever Virus Vaccine Strain 17D for Intratumoral Therapy in a Murine Model of … DOI 10.3390/vaccines13010040↗
How to reach this person
A chain of introductions through people who have published, run trials or held grants together (warm_path@1: fewest links first, then the strongest). Built from public records only; no contact details are kept.